Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Vesicular monoamine transporter inhibitors versus placebo for antipsychotic‐induced tardive dyskinesia

Information

DOI:
https://doi.org/10.1002/14651858.CD012986Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 22 March 2018see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:
  1. Cochrane Schizophrenia Group

Copyright:
  1. Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Boris Karl

    Kimbolton School, Huntingdon, UK

  • Hanna Bergman

    Cochrane Response, Cochrane, London, UK

  • Sarah Abd El Sayed

    The Pear Tree Centre, Worcestershire Health and Care NHS Trust, Redditch, UK

  • Clive E Adams

    Correspondence to: Cochrane Schizophrenia Group, The University of Nottingham, Nottingham, UK

    [email protected]

Contributions of authors

BK ‐ drafted the protocol

HB ‐ drafted the protocol

SAS ‐ checked final version

CEA ‐ drafted the protocol

Sources of support

Internal sources

  • Kimbolton School, UK.

  • University of Nottingham, UK.

External sources

  • No sources of support supplied

Declarations of interest

BK ‐ None

HB ‐ Hanna Bergman has a consultancy contract with Cochrane Response, an evidence services unit operated by the Cochrane Collaboration, to carry out systematic reviews on various topics.

SAS ‐ None

CEA ‐ None

Acknowledgements

The Cochrane Schizophrenia Group Editorial Base at The University of Nottingham, Nottingham, UK, produces and maintains standard text for use in the Methods section of their reviews. We have used this text as the basis of what appears here and adapted it as required.

We thank Christina Kaewchaluay for peer reviewing this protocol.

Version history

Published

Title

Stage

Authors

Version

2018 Mar 22

Vesicular monoamine transporter inhibitors versus placebo for antipsychotic‐induced tardive dyskinesia

Protocol

Boris Karl, Hanna Bergman, Sarah Abd El Sayed, Clive E Adams

https://doi.org/10.1002/14651858.CD012986

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.

Deutetrabenazine (3R,11bR)‐3‐(2‐methylpropyl)‐9,10‐bis(trideuteriomethoxy)‐1,3,4,6,7,11b‐hexahydrobenzo[a]quinolizin‐2‐one
Figures and Tables -
Figure 1

Deutetrabenazine (3R,11bR)‐3‐(2‐methylpropyl)‐9,10‐bis(trideuteriomethoxy)‐1,3,4,6,7,11b‐hexahydrobenzo[a]quinolizin‐2‐one

Valbenazine (2R,3R,11bR)‐3‐isobutyl‐9,10‐dimethoxy‐1,3,4,6,7,11b‐hexahydro‐2H‐pyrido[2,1‐a]isoquinolin‐2‐yl L‐valinate)
Figures and Tables -
Figure 2

Valbenazine (2R,3R,11bR)‐3‐isobutyl‐9,10‐dimethoxy‐1,3,4,6,7,11b‐hexahydro‐2H‐pyrido[2,1‐a]isoquinolin‐2‐yl L‐valinate)

Message from one of the participants in the public and patient involvement consultation of service‐user perspectives on tardive dyskinesia research
Figures and Tables -
Figure 3

Message from one of the participants in the public and patient involvement consultation of service‐user perspectives on tardive dyskinesia research

Table 1. Other Cochrane Reviews in this series

Interventions

Current reference(s) (updates underway)

Anticholinergic medication

Soares 2000; Soares‐Weiser 1997

Benzodiazepines

Bhoopathi 2006

Calcium‐channel blockers

Essali 2011

Cholinergic medication

Tammenmaa 2002

Gamma‐aminobutyric acid agonists

Alabed 2011

Miscellaneous treatments

Soares‐Weiser 2003

Antipsychotic reduction orcessation, or both, and neuroleptics

Soares‐Weiser 2006

Non‐neuroleptic catecholaminergic drugs

El‐Sayeh 2006

Vitamin E

Soares‐Weiser 2011

Figures and Tables -
Table 1. Other Cochrane Reviews in this series